Treatment-free survival (TFS) outcomes from the phase II study of nivolumab and salvage nivolumab + ipilimumab in advanced clear cell renal cell carcinoma (aRCC) (HCRN GU16-260-Cohort A)

Atkins, Michael B. ; Jegede, Opeyemi ; McDermott, David F. ; Haas, Naomi B. ; Bilen, Mehmet Asim ; Stein, Mark N. ; Sosman, Jeffrey A. ; Plimack, Elizabeth R. ; Alter, Robert S. ; Ornstein, Moshe Chaim ; Hurwitz, Michael E. ; Peace, David J. ; Einstein, David Johnson ; Catalano, Paul J. ; Hammers, Hans J. ; Regan, Meredith M.

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.604-604 [Periódico revisado por pares]

Texto completo disponível